Intermittent Claudication Market, Global Outlook and Forecast 2023-2028

Report ID: 1134910 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Intermittent Claudication Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Intermittent Claudication Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Intermittent Claudication Overall Market Size
    2.1 Global Intermittent Claudication Market Size: 2021 VS 2028
    2.2 Global Intermittent Claudication Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Intermittent Claudication Players in Global Market
    3.2 Top Global Intermittent Claudication Companies Ranked by Revenue
    3.3 Global Intermittent Claudication Revenue by Companies
    3.4 Top 3 and Top 5 Intermittent Claudication Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Intermittent Claudication Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Intermittent Claudication Players in Global Market
        3.6.1 List of Global Tier 1 Intermittent Claudication Companies
        3.6.2 List of Global Tier 2 and Tier 3 Intermittent Claudication Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Intermittent Claudication Market Size Markets, 2021 & 2028
        4.1.2 Medication Therapies
        4.1.3 Revascularization
    4.2 By Type - Global Intermittent Claudication Revenue & Forecasts
        4.2.1 By Type - Global Intermittent Claudication Revenue, 2017-2022
        4.2.2 By Type - Global Intermittent Claudication Revenue, 2023-2028
        4.2.3 By Type - Global Intermittent Claudication Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Intermittent Claudication Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Home Healthcare
        5.1.5 Others
    5.2 By Application - Global Intermittent Claudication Revenue & Forecasts
        5.2.1 By Application - Global Intermittent Claudication Revenue, 2017-2022
        5.2.2 By Application - Global Intermittent Claudication Revenue, 2023-2028
        5.2.3 By Application - Global Intermittent Claudication Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Intermittent Claudication Market Size, 2021 & 2028
    6.2 By Region - Global Intermittent Claudication Revenue & Forecasts
        6.2.1 By Region - Global Intermittent Claudication Revenue, 2017-2022
        6.2.2 By Region - Global Intermittent Claudication Revenue, 2023-2028
        6.2.3 By Region - Global Intermittent Claudication Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Intermittent Claudication Revenue, 2017-2028
        6.3.2 US Intermittent Claudication Market Size, 2017-2028
        6.3.3 Canada Intermittent Claudication Market Size, 2017-2028
        6.3.4 Mexico Intermittent Claudication Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Intermittent Claudication Revenue, 2017-2028
        6.4.2 Germany Intermittent Claudication Market Size, 2017-2028
        6.4.3 France Intermittent Claudication Market Size, 2017-2028
        6.4.4 U.K. Intermittent Claudication Market Size, 2017-2028
        6.4.5 Italy Intermittent Claudication Market Size, 2017-2028
        6.4.6 Russia Intermittent Claudication Market Size, 2017-2028
        6.4.7 Nordic Countries Intermittent Claudication Market Size, 2017-2028
        6.4.8 Benelux Intermittent Claudication Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Intermittent Claudication Revenue, 2017-2028
        6.5.2 China Intermittent Claudication Market Size, 2017-2028
        6.5.3 Japan Intermittent Claudication Market Size, 2017-2028
        6.5.4 South Korea Intermittent Claudication Market Size, 2017-2028
        6.5.5 Southeast Asia Intermittent Claudication Market Size, 2017-2028
        6.5.6 India Intermittent Claudication Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Intermittent Claudication Revenue, 2017-2028
        6.6.2 Brazil Intermittent Claudication Market Size, 2017-2028
        6.6.3 Argentina Intermittent Claudication Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Intermittent Claudication Revenue, 2017-2028
        6.7.2 Turkey Intermittent Claudication Market Size, 2017-2028
        6.7.3 Israel Intermittent Claudication Market Size, 2017-2028
        6.7.4 Saudi Arabia Intermittent Claudication Market Size, 2017-2028
        6.7.5 UAE Intermittent Claudication Market Size, 2017-2028
7 Players Profiles
    7.1 I'ROM GROUP(DNAVEC Corporation)
        7.1.1 I'ROM GROUP(DNAVEC Corporation) Corporate Summary
        7.1.2 I'ROM GROUP(DNAVEC Corporation) Business Overview
        7.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Major Product Offerings
        7.1.4 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue in Global Market (2017-2022)
        7.1.5 I'ROM GROUP(DNAVEC Corporation) Key News
    7.2 Nuo Therapeutics Inc.
        7.2.1 Nuo Therapeutics Inc. Corporate Summary
        7.2.2 Nuo Therapeutics Inc. Business Overview
        7.2.3 Nuo Therapeutics Inc. Intermittent Claudication Major Product Offerings
        7.2.4 Nuo Therapeutics Inc. Intermittent Claudication Revenue in Global Market (2017-2022)
        7.2.5 Nuo Therapeutics Inc. Key News
    7.3 Kowa Company Ltd.
        7.3.1 Kowa Company Ltd. Corporate Summary
        7.3.2 Kowa Company Ltd. Business Overview
        7.3.3 Kowa Company Ltd. Intermittent Claudication Major Product Offerings
        7.3.4 Kowa Company Ltd. Intermittent Claudication Revenue in Global Market (2017-2022)
        7.3.5 Kowa Company Ltd. Key News
    7.4 LTT Bio-Pharma
        7.4.1 LTT Bio-Pharma Corporate Summary
        7.4.2 LTT Bio-Pharma Business Overview
        7.4.3 LTT Bio-Pharma Intermittent Claudication Major Product Offerings
        7.4.4 LTT Bio-Pharma Intermittent Claudication Revenue in Global Market (2017-2022)
        7.4.5 LTT Bio-Pharma Key News
    7.5 Pluristem Therapeutics Inc.
        7.5.1 Pluristem Therapeutics Inc. Corporate Summary
        7.5.2 Pluristem Therapeutics Inc. Business Overview
        7.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Major Product Offerings
        7.5.4 Pluristem Therapeutics Inc. Intermittent Claudication Revenue in Global Market (2017-2022)
        7.5.5 Pluristem Therapeutics Inc. Key News
    7.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
        7.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
        7.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Business Overview
        7.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Major Product Offerings
        7.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue in Global Market (2017-2022)
        7.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Key News
    7.7 Genovate Biotechnology Co., Ltd.
        7.7.1 Genovate Biotechnology Co., Ltd. Corporate Summary
        7.7.2 Genovate Biotechnology Co., Ltd. Business Overview
        7.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Major Product Offerings
        7.7.4 Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue in Global Market (2017-2022)
        7.7.5 Genovate Biotechnology Co., Ltd. Key News
    7.8 Novartis AG
        7.8.1 Novartis AG Corporate Summary
        7.8.2 Novartis AG Business Overview
        7.8.3 Novartis AG Intermittent Claudication Major Product Offerings
        7.8.4 Novartis AG Intermittent Claudication Revenue in Global Market (2017-2022)
        7.8.5 Novartis AG Key News
    7.9 ID Pharma Co., Ltd
        7.9.1 ID Pharma Co., Ltd Corporate Summary
        7.9.2 ID Pharma Co., Ltd Business Overview
        7.9.3 ID Pharma Co., Ltd Intermittent Claudication Major Product Offerings
        7.9.4 ID Pharma Co., Ltd Intermittent Claudication Revenue in Global Market (2017-2022)
        7.9.5 ID Pharma Co., Ltd Key News
    7.10 Helixmith Co., Ltd.
        7.10.1 Helixmith Co., Ltd. Corporate Summary
        7.10.2 Helixmith Co., Ltd. Business Overview
        7.10.3 Helixmith Co., Ltd. Intermittent Claudication Major Product Offerings
        7.10.4 Helixmith Co., Ltd. Intermittent Claudication Revenue in Global Market (2017-2022)
        7.10.5 Helixmith Co., Ltd. Key News
    7.11 G. Pohl-Boskamp GmbH & Co. KG
        7.11.1 G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
        7.11.2 G. Pohl-Boskamp GmbH & Co. KG Business Overview
        7.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Major Product Offerings
        7.11.4 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue in Global Market (2017-2022)
        7.11.5 G. Pohl-Boskamp GmbH & Co. KG Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Intermittent Claudication Market Opportunities & Trends in Global Market
    Table 2. Intermittent Claudication Market Drivers in Global Market
    Table 3. Intermittent Claudication Market Restraints in Global Market
    Table 4. Key Players of Intermittent Claudication in Global Market
    Table 5. Top Intermittent Claudication Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Intermittent Claudication Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Intermittent Claudication Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Intermittent Claudication Product Type
    Table 9. List of Global Tier 1 Intermittent Claudication Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Intermittent Claudication Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Intermittent Claudication Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Intermittent Claudication Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Intermittent Claudication Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Intermittent Claudication Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Intermittent Claudication Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Intermittent Claudication Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Intermittent Claudication Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Intermittent Claudication Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Intermittent Claudication Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Intermittent Claudication Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Intermittent Claudication Revenue, (US$, Mn), 2023-2028
    Table 30. I'ROM GROUP(DNAVEC Corporation) Corporate Summary
    Table 31. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product Offerings
    Table 32. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 33. Nuo Therapeutics Inc. Corporate Summary
    Table 34. Nuo Therapeutics Inc. Intermittent Claudication Product Offerings
    Table 35. Nuo Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 36. Kowa Company Ltd. Corporate Summary
    Table 37. Kowa Company Ltd. Intermittent Claudication Product Offerings
    Table 38. Kowa Company Ltd. Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 39. LTT Bio-Pharma Corporate Summary
    Table 40. LTT Bio-Pharma Intermittent Claudication Product Offerings
    Table 41. LTT Bio-Pharma Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 42. Pluristem Therapeutics Inc. Corporate Summary
    Table 43. Pluristem Therapeutics Inc. Intermittent Claudication Product Offerings
    Table 44. Pluristem Therapeutics Inc. Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 45. Nuo Therapeutics, Inc.(Aldagen, Inc.) Corporate Summary
    Table 46. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product Offerings
    Table 47. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 48. Genovate Biotechnology Co., Ltd. Corporate Summary
    Table 49. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product Offerings
    Table 50. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 51. Novartis AG Corporate Summary
    Table 52. Novartis AG Intermittent Claudication Product Offerings
    Table 53. Novartis AG Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 54. ID Pharma Co., Ltd Corporate Summary
    Table 55. ID Pharma Co., Ltd Intermittent Claudication Product Offerings
    Table 56. ID Pharma Co., Ltd Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 57. Helixmith Co., Ltd. Corporate Summary
    Table 58. Helixmith Co., Ltd. Intermittent Claudication Product Offerings
    Table 59. Helixmith Co., Ltd. Intermittent Claudication Revenue (US$, Mn), (2017-2022)
    Table 60. G. Pohl-Boskamp GmbH & Co. KG Corporate Summary
    Table 61. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product Offerings
    Table 62. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Intermittent Claudication Segment by Type in 2021
    Figure 2. Intermittent Claudication Segment by Application in 2021
    Figure 3. Global Intermittent Claudication Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Intermittent Claudication Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Intermittent Claudication Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Intermittent Claudication Revenue in 2021
    Figure 8. By Type - Global Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 12. US Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 16. Germany Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 17. France Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 24. China Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 28. India Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 30. Brazil Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Intermittent Claudication Revenue Market Share, 2017-2028
    Figure 33. Turkey Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Intermittent Claudication Revenue, (US$, Mn), 2017-2028
    Figure 37. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Nuo Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Kowa Company Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. LTT Bio-Pharma Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Pluristem Therapeutics Inc. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Novartis AG Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. ID Pharma Co., Ltd Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Helixmith Co., Ltd. Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Intermittent Claudication Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Intermittent Claudication Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Intermittent Claudication Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports